Member Info for 13thmonkey

It's not purgeable, I asked, so it's test and replace, not test-read-reset. Which means lots of reordering of affimers, not a lot of volume compared to what they could be, but repeating stream. At the moment they can't multiplex to treat several things at once but they are planning for that, so several different affimers per cartridge.

Previously they've said both, don't know why, costs they think will come down as it's ripe for very high volume manufacturing. The digital aspect is a massive plus point in my opinion. I'm in both.

The government constantly give contracts to the tax minimising big 4, and abject failures like serco. So giving a contract to a company who has a supplier who are owned by directors who own a company that's having some difficulty with those big 4 auditors is almost guaranteed.

You don't develop antibodies until you've been infectious for a while, either if you end up being symptomatic or asymptomatic. So to test if you are safe to be in the general population it's not very useful.

The hat, Eli and another globalco is better than just Eli (not that just Eli is a bad thing), that's why it matters.

I know that globalco was previously announced as Eli Lilly, this leads to two possible conclusions.
1. They are still referring to Eli as globalco where they no longer need to.
2. They are referring to a different party who wishes to remain anonymous.
Are you suggesting that scenario 1 is what's happening?

This reminds of a question I posed ages ago, can affimers assist in drug resistant infections, if they can there is a very large market there that is crying out for novel solutions.

They're doing what now?

Isn't there specific mention of NDAs being required as a part of condor, no idea why, but I seem to recall that.

It's odd, hours before this RNS jgb seemed to say this was bau and therefore not worth an RNS. Maybe they reconsidered this. But I'm not clear whether in the UK we're doing this with mwg/dvrg, I recognise that testing facilities we're involved with in China are being set to be upgraded, which is newsworthy in itself.

Haven't all of those that have had press coverage at early stages gone and been found out? Has there been any positive news stories that have not just fallen by the wayside? Maybe noyacyte, but it's only the last 6 weeks where it's gone above £2.50.
Let's just leave the press to where got something, else there'll be more whining that it's taking too long from sun and mirror readers.

He said on Twitter that it was bau so no need for an RNS, glad he changed his mind.

Nothing of below 500k

Don't throw them in the fricking Ocean then.

And your point is?

2.5% including options about 30% I think excluding options.

Pilgrim, antibody test, not antigen.

Yes, it attracts all sorts of comedians who give classes in being obvious with their intentions

Were you going sell before news? Nope, then you've lost nothing. If you were you're a trader, and news will arrive that's positive and negative, that's the risk of shorter term positions.

Are you selling in the immediate future? If not then why worry? The use of words like idiotic is really uncalled for.